Top Markets
Coin of the day
Blue Water Vaccines, Inc. Blue Water Vaccines, Inc.

Blue Water Vaccines, Inc.

BWV
Rank in Stocks #36371
Blue Water Vaccines, Inc. (BWV) operates as a biotechnology firm dedicated to... Blue Water Vaccines, Inc. (BWV) operates as a biotechnology firm dedicated to the worldwide discovery and development of vaccines aimed at preventing infectious diseases. Currently in preclinical stages, their most prominent vaccine candidates are BWV-101, an influenza shot, and BWV-102, designed to counter H1 pre-pandemic threats. The company's developmental portfolio also includes other preclinical programs such as BWV-201, a vaccine addressing acute otitis media caused by Streptococcus pneumoniae; BWV-301, a combined vaccine for norovirus and rotavirus; and BWV-302, a dual-target vaccine for norovirus and malaria. Founded in 2018, BWV's operations are based in Cincinnati, Ohio.
Share Price
$0.1735
Last synced: 2024-01-16
Market Cap
$2.76M
Change (1 day)
-3.82%
Change (1 year)
0.00%
Country
US
Trade Blue Water Vaccines, Inc. (BWV)

Category

P/S ratio for Blue Water Vaccines, Inc. (BWV)
P/S ratio as of 2026 TTM: 0
According to Blue Water Vaccines, Inc. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Blue Water Vaccines, Inc. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
10.17 -
US
10.13 -
NL
- -
CH
- -
KR
4.74 -
BE